A Mini Review on Genes Associated with in vitro and in vivo Carbon Nanotubes Toxicity

Authors

  • V. Vijayalakshmi
  • Bindu Sadanandan

Abstract

Carbon nanotubes (CNTs) are the most extensively used nanomaterials due to their unique properties and diverse applications. The potential toxicity caused due to the exposure of CNTs in vitro and in vivo is being widely studied. This mini review provides information about the genes responsible for inflammatory, fibrotic and apoptotic responses during single and multi-walled CNT toxicity. Based on published literature, the upregulated pro-inflammatory genes are EGR1, ATF3, FGF21, EGF1 and CD9 and downregulated ones are TOB2, CD47, FOXO3 and RORA. The genes associated with fibrosis are MMP-2, MMP-8, IL23A, EDNRA, MMP-9, TIMP-1, CDK4, UBD and with apoptosis are p16, bax, hrk, bak1, p53, p57 and FGFR2. This mini review is an attempt at compiling the genes responsible for CNT toxicity. Future work aims at creating a database of genes associated with CNT toxicity.

 

Keywords: Carbon nanotubes (CNTs), genes, in vitro, in vivo, toxicity

Cite this Article

V. Vijayalakshmi, Bindu Sadanandan. A Mini Review on Genes Associated with in vitro and in vivo Carbon Nanotubes Toxicity. Research & Reviews: A Journal of Life Sciences. 2019; 9(Issue 1 Special): 73s–78s.

Downloads

Published

2019-06-26

Issue

Vol. 9 No. 1 (2019)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.